1. A step towards precision medicine in management of severe transient polyhydramnios: MAGED2 variant
- Author
-
Tiphaine Bihouée, Norbert Winer, Mathilde Nizon, Nadir Benbrik, Martin Kömhoff, Vera Riehmer, Bodo B. Beck, Alexandra Bruel, Chloé Arthuis, Bertrand Isidor, Service de Gynécologie Obstétrique (NANTES - Gynéco Obstétrique), Centre hospitalier universitaire de Nantes (CHU Nantes), Philipps University of Marburg, Institute of Human Genetics, Universität Ulm - Ulm University [Ulm, Allemagne], University of Cologne, Service de Pédiatrie, Physiopathologie des Adaptations Nutritionnelles (PhAN), and Université de Nantes (UN)-Institut National de la Recherche Agronomique (INRA)
- Subjects
Male ,Polyhydramnios ,medicine.medical_specialty ,030232 urology & nephrology ,Excessive amniotic fluid ,Infant, Premature, Diseases ,génétique ,Young Adult ,03 medical and health sciences ,0302 clinical medicine ,Antigens, Neoplasm ,Pregnancy ,Internal medicine ,medicine ,Humans ,030212 general & internal medicine ,gynécologie ,ComputingMilieux_MISCELLANEOUS ,perinatal ,Adaptor Proteins, Signal Transducing ,business.industry ,fungi ,Infant, Newborn ,Bartter Syndrome ,food and beverages ,Obstetrics and Gynecology ,fluide ,medicine.disease ,Precision medicine ,Pedigree ,3. Good health ,Increased risk ,Mutation ,Cardiology ,[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie ,Female ,business ,[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology - Abstract
Polyhydramnios is a recurrent clinical concern. Excessive amniotic fluid can be caused by an imbalance between its production and its removal, and is associated with an increased risk of an adverse...
- Published
- 2018